Cellectar Biosciences (CLRB) Institutional Ownership $1.48 -0.08 (-5.26%) (As of 10:27 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cellectar Biosciences (NASDAQ:CLRB)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$19.31MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$5.86M Get CLRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Cellectar Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLRB Institutional Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Cellectar Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC120,497$258K0.0%-30.0%0.297% 11/16/2024 Geode Capital Management LLC352,452$754K0.0%+3.3%0.869% 11/15/2024 Barclays PLC120,497$258K0.0%-30.0%0.297% 11/15/2024 XTX Topco Ltd53,022$113K0.0%-16.2%0.131% 11/6/2024 Oppenheimer & Co. Inc.12,500$27K0.0%N/A0.031% 10/30/2024 Rosalind Advisors Inc.3,671,550$7.86M4.9%+35.7%10.241% Get the Latest News and Ratings for CLRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/22/2024 Sequoia Financial Advisors LLC23,800$51K0.0%N/A0.066% 8/20/2024 Nantahala Capital Management LLC1,833,325$4.58M0.3%-2.1%5.114% 8/16/2024 Coastal Bridge Advisors LLC11,000$28K0.0%-31.3%0.031% 8/12/2024 XTX Topco Ltd63,304$158K0.0%+432.4%0.177% 8/7/2024 AIGH Capital Management LLC3,036,187$7.59M2.4%+8.2%8.469% 7/12/2024 Rosalind Advisors Inc.2,705,616$6.76M5.0%+335.4%7.547% 5/10/2024 Vanguard Group Inc.1,191,081$4.74M0.0%+146.7%3.322% 4/25/2024 Rosalind Advisors Inc.621,478$2.47M2.3%-69.0%1.926% 2/14/2024 ADAR1 Capital Management LLC1,378,082$3.82M1.4%N/A11.213% 2/12/2024 AIGH Capital Management LLC1,915,220$5.31M2.1%+182.7%15.584% 2/9/2024 Worth Venture Partners LLC693,909$1.92M1.0%+148.6%5.646% 1/1/2024 Vanguard Group Inc.175,884$464K0.0%+2.3%1.431% 11/15/2023 Worth Venture Partners LLC279,123$737K0.4%-11.0%2.808% 11/15/2023 Acuta Capital Partners LLC121,300$320K0.2%N/A1.220% 11/13/2023 AIGH Capital Management LLC677,511$1.79M0.8%-16.7%6.816% 7/21/2023 1900 Wealth Management LLC18,000$35K0.0%+50.0%0.185% 2/16/2023 AIGH Capital Management LLC931,888$1.59M0.5%+434.3%9.924% 11/16/2022 Maven Securities LTD25,000$84K0.0%-93.8%0.266% 11/14/2022 Worth Venture Partners LLC41,636$140K0.1%-90.9%0.444% 11/14/2022 Maven Securities LTD25,000$84K0.0%-93.8%0.266% 11/3/2022ACT Capital Management LLC21,750$73K0.1%-90.0%0.356% 10/31/2022 1900 Wealth Management LLC12,000$40K0.0%N/A0.196% 5/12/2022 AIGH Capital Management LLC1,837,046$1.26M0.3%+104.9%3.007% 4/27/2022 1900 Wealth Management LLC120,000$83K0.0%+100.0%0.196% 2/14/2022 Maven Securities LTD400,000$266K0.0%-60.4%0.655% 2/10/2022 AIGH Capital Management LLC896,590$596K0.2%N/A1.467% 11/15/2021 Franklin Resources Inc.142,400$132K0.0%N/A0.233% 11/12/2021 Renaissance Technologies LLC447,074$414K0.0%-55.8%0.732% 11/5/2021 Cozad Asset Management Inc.51,000$47K0.0%+64.5%0.083% 9/17/2021Virtu Financial LLC49,780$59K0.0%N/A0.081% 8/17/2021PVG Asset Management Corp193,510$230K0.7%+1,804.6%0.317% 8/16/2021 Maven Securities LTD650,000$793K0.0%-27.8%1.064% 8/16/2021 State Street Corp147,846$176K0.0%N/A0.242% 8/16/2021 Sabby Management LLC426,561$508K0.1%+9.6%0.698% JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late.8/13/2021 Renaissance Technologies LLC1,011,268$1.20M0.0%+13.3%1.655% 8/13/2021QS Investors LLC142,400$170K0.0%N/A0.233% 8/13/2021 Geode Capital Management LLC397,170$472K0.0%+62.5%0.650% 8/13/2021 Vanguard Group Inc.1,874,584$2.23M0.0%+14.1%3.068% 8/5/2021 GSA Capital Partners LLP297,653$354K0.0%+90.0%0.564% 8/4/2021 Envestnet Asset Management Inc.104,385$124K0.0%+354.3%0.198% 8/2/2021 Advisor Group Holdings Inc.23,827$28K0.0%+221.4%0.045% 8/1/2021 Sterneck Capital Management LLC30,000$34K0.0%N/A0.057% 7/29/2021 Cozad Asset Management Inc.31,000$37K0.0%+181.8%0.059% 5/19/2021 Squarepoint Ops LLC136,942$220K0.0%N/A0.260% 5/18/2021 Millennium Management LLC246,485$397K0.0%+1,249.3%0.467% 5/18/2021 Silverarc Capital Management LLC606,358$976K0.5%-65.8%1.150% 5/14/2021 Dimensional Fund Advisors LP21,265$34K0.0%-33.8%0.040% 5/13/2021 Renaissance Technologies LLC892,557$1.44M0.0%+229.5%1.693% 5/12/2021 Northern Trust Corp95,438$154K0.0%+114.8%0.181% 5/12/2021 Geode Capital Management LLC244,392$393K0.0%+84.6%0.464% 5/10/2021 GSA Capital Partners LLP156,696$252K0.0%N/A0.297% 5/4/2021 Envestnet Asset Management Inc.22,979$37K0.0%+87.4%0.045% 5/4/2021Commonwealth Equity Services LLC22,945$36K0.0%+48.8%0.045% 4/30/2021 Creative Planning30,000$48K0.0%N/A0.059% 3/8/2021 Dimensional Fund Advisors LP32,146$67K0.0%N/A0.064% 2/25/2021 Dimensional Fund Advisors LP32,146$67K0.0%N/A0.071% 2/24/2021Virtu Financial LLC226,837$472K0.1%N/A0.499% 2/16/2021 Silverarc Capital Management LLC1,772,848$3.69M2.1%N/A3.901% 2/16/2021 Tri Locum Partners LP658,373$1.37M0.5%N/A1.449% 2/16/2021 Prelude Capital Management LLC130,208$271K0.0%N/A0.286% 2/10/2021 Renaissance Technologies LLC270,865$563K0.0%-38.6%0.596% 2/9/2021 Bank of New York Mellon Corp31,709$66K0.0%N/A0.070% 2/5/2021BlackRock Inc.709,909$1.48M0.0%+1,203,135.6%1.562% 1/19/2021FNY Investment Advisers LLC220,321$458K0.1%+8.4%0.485% 11/16/2020 Worth Venture Partners LLC175,350$218K0.2%-56.1%0.654% 11/12/2020 Quilter Plc58,102$72K0.0%-57.6%0.217% (Data available from 1/1/2016 forward) CLRB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLRB shares? During the previous two years, 14 institutional investors and hedge funds held shares of Cellectar Biosciences. The most heavily invested institutionals were Rosalind Advisors Inc. ($7.86M), AIGH Capital Management LLC ($7.59M), Vanguard Group Inc. ($4.74M), Nantahala Capital Management LLC ($4.58M), ADAR1 Capital Management LLC ($3.82M), Worth Venture Partners LLC ($1.92M), and Geode Capital Management LLC ($754K).Learn more on CLRB's institutional investors. What percentage of Cellectar Biosciences stock is owned by institutional investors? 16.41% of Cellectar Biosciences stock is owned by institutional investors. Learn more on CLRB's institutional investor holdings. Which institutional investors have been buying Cellectar Biosciences stock? Of the 11 institutional investors that purchased Cellectar Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rosalind Advisors Inc. ($3.05M), AIGH Capital Management LLC ($2.23M), ADAR1 Capital Management LLC ($1.38M), Vanguard Group Inc. ($712.10K), Worth Venture Partners LLC ($414.79K), Acuta Capital Partners LLC ($121.30K), and XTX Topco Ltd ($51.41K). How much institutional buying is happening at Cellectar Biosciences? Institutional investors have bought a total of 8,007,766 shares in the last 24 months. This purchase volume represents approximately $20.94M in transactions. Which Cellectar Biosciences major shareholders have been selling company stock? The following institutional investors have sold Cellectar Biosciences stock in the last 24 months: Rosalind Advisors Inc. ($1.38M), AIGH Capital Management LLC ($135.69K), Barclays PLC ($103.40K), Nantahala Capital Management LLC ($40K), Worth Venture Partners LLC ($34.39K), XTX Topco Ltd ($10.28K), and Coastal Bridge Advisors LLC ($5K). How much institutional selling is happening at Cellectar Biosciences? Institutional investors have sold a total of 1,712,934 shares in the last 24 months. This volume of shares sold represents approximately $6.31M in transactions. Related Companies OCUP Major Shareholders BNTC Major Shareholders ACB Major Shareholders NGNE Major Shareholders BMEA Major Shareholders CYBN Major Shareholders ZNTL Major Shareholders GNFT Major Shareholders STRO Major Shareholders TCRX Major Shareholders This page (NASDAQ:CLRB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectar Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
